Organon (OGN) and Samsung Bioepis Announce FDA Approval of HADLIMA
Go back to Organon (OGN) and Samsung Bioepis Announce FDA Approval of HADLIMA(NYSE: OGN) | Delayed: 17.86 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $17.86 | 52 Week High | $8.00 | |||
Open | $17.86 | 52 Week Low | $8.00 | |||
Day High | $17.86 | P/E | N/A | |||
Day Low | $17.86 | EPS | $0.00 | |||
Volume | 72 |